Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Prostate cancer nomograms are valuable tools for the discussion of treatment options with patients, but their ability to change patient decisions or improve outcomes remains unproven. In this Viewpoint, Alan Stapleton and Carole Pinnock discuss the limitations and uncertainties surrounding these tools, such as changes in source population clinical profiles over time, and parallel changes in the usefulness of prognostic factors.